{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:59:31Z","timestamp":1780995571827,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ahj.2013.08.005","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T17:31:27Z","timestamp":1379439087000},"page":"864-870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Warfarin use among older atrial fibrillation patients with non\u2013ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy"],"prefix":"10.1016","volume":"166","author":[{"given":"Emil L.","family":"Fosbol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger M.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winslow","family":"Klaskala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2013.08.005_bb0005","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurheartj\/ehq117","volume":"31","author":"Lip","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.08.005_bb0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/07853890802089786","article-title":"Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation","volume":"40","author":"Rubboli","year":"2008","journal-title":"Ann Med"},{"key":"10.1016\/j.ahj.2013.08.005_bb0015","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/eurheartj\/ehp213","article-title":"Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial","volume":"30","author":"Lopes","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.08.005_bb0020","first-page":"1146","article-title":"Improving the care of patients with non\u2013ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative","volume":"9","author":"Hoekstra","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ahj.2013.08.005_bb0025","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ahj.2009.04.002","article-title":"Linking inpatient clinical registry data to Medicare claims data using indirect identifiers","volume":"157","author":"Hammill","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.08.005_bb0030","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jacc.2010.09.069","article-title":"Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction","volume":"57","author":"S\u00f8rensen","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.08.005_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","article-title":"Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records","volume":"148","author":"Kiyota","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.08.005_bb0040","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors","volume":"43","author":"Birman-Deych","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2013.08.005_bb0045","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2013.08.005_bb0050","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non\u2013ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA Guidelines) Bleeding Score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.08.005_bb0055","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2013.08.005_bb0060","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.08.005_bb0065","doi-asserted-by":"crossref","unstructured":"Roe MT, Chen AY, Thomas L, et al. Predicting long-term mortality in older patients following non\u2013ST-elevation myocardial infarction: the CRUSADE long-term mortality model. Am Heart J 2011;162:875-83.e1.","DOI":"10.1016\/j.ahj.2011.08.010"},{"key":"10.1016\/j.ahj.2013.08.005_bb0070","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIR.0b013e3181fa3cf4","article-title":"2011 ACCF\/AHA\/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"123","author":"Wann","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.08.005_bb0075","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ahj.2012.01.017","article-title":"Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non\u2013ST elevation myocardial infarction","volume":"163","author":"Fosbol","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.08.005_bb0080","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2013.08.005_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4330\/wjc.v2.i3.64","article-title":"Antithrombotic management of patients on oral anticoagulation undergoing coronary artery stenting","volume":"2","author":"Rubboli","year":"2010","journal-title":"World J Cardiol"},{"key":"10.1016\/j.ahj.2013.08.005_bb0090","unstructured":"A study exploring two strategies of rivaroxaban and one of oral vitamin k antagonist in patients with atrial fibrillation who undergo percutaneous coronary intervention. ClinicalTrials.gov web site. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01830543?term=PIONEER+AF-PCI&rank=1. Updated June 20, 2013. Accessed June 24, 2013."},{"key":"10.1016\/j.ahj.2013.08.005_bb0095","unstructured":"Anticoagulation in Stent Intervention (MUSICA-2). ClinicalTrials.gov web site. http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01141153?term=NCT01141153&rank=1. Updated January 4, 2012. Accessed November 13, 2012."},{"key":"10.1016\/j.ahj.2013.08.005_bb0100","unstructured":"Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation (ISAR-TRIPLE). ClinicalTrials.gov web site. http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00776633?term=nct00776633&rank=1. Updated January 3, 2012. Accessed November 13, 2012."},{"key":"10.1016\/j.ahj.2013.08.005_bb0105","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomized, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2013.08.005_bb0110","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.08.005_bb0115","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.08.005_bb0120","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.08.005_bb0125","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.08.005_bb0130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","volume":"60","author":"Apostolakis","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.08.005_bb0135","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/CIRCEP.112.972869","article-title":"Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project","volume":"5","author":"Lip","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313005292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313005292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:50:44Z","timestamp":1757569844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870313005292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0002870313005292"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2013.08.005","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Warfarin use among older atrial fibrillation patients with non\u2013ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2013.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}